IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
Sai Parenteral's IPO is a Book Building IPO listing on BSE,NSE exchange, with an ipo size of ₹ [●] Cr. The company is based in Telengana and caters to Pharmaceutical sector. Arihant Capital Markets is the merchant banker of Sai Parenteral's IPO. It is a MainBoard Upcoming IPO which filed its Draft Red Herring Prospectus (DRHP) on 30th September 2025. Sai Parenteral's IPO open date is [●] and close date is [●]. IPO Allotment Date is [●] and Listing date is [●].
IPO
Size:
₹ Cr.
Avg IPO Size (Sector Based)
: ₹
1,326.67 cr.
Sector: Pharmaceutical
IPO so far:
25
Merchant Banker:
Arihant Capital
IPO by BRLM so far:
4
City:
Telengana
IPO so far:
0
Revenue (annualised):
₹
163.10
cr. 
PE
Ratio:
x
Average Sector PE Ratio: 27.74x
Sai Parenteral's IPO size is ₹ [●] with IPO price of ₹ [●]. IPO subscription will start on IPO open date and end on IPO close date as per above. IPO valuation metrics can be seen here.
| Particulars | Amount |
|---|---|
| Capacity expansion and upgradation of manufacturing facilities | [●] |
| Establishment of a new R&D Centre | [●] |
| Repayment / prepayment of certain outstanding borrowings | [●] |
| Working capital requirements | [●] |
| Investment in wholly owned subsidiary, Sai Parenterals Pte Limited (Singapore), in relation to the proposed acquisition of Noumed Pharmaceuticals Pty Limited (Australia) | [●] |
| General corporate purposes | [●] |
| Offer expenses | [●] |
Arihant Capital Markets Limited is the book-running lead manager of the Sai Parenteral's IPO. Bigshare Services Private Limited is the Registrar for Sai Parenteral's IPO.
Sai Parenteral's IPO Draft red herring prospectus (DRHP) and Red Herring prospectus (RHP) are available below.
Sai Parenteral's IPO, based in Telengana, operates in the Pharmaceutical sector with a focus on Diversified pharmaceutical formulations company. The company is launching its MainBoard Upcoming IPO on the BSE,NSE exchange, using the Book Building Issue method. Sai Parenteral's IPO size is ₹ [●] with fresh issue size of ₹ 0 Cr. and Offer for sale being ₹ Nil
The IPO allotment date for Sai Parenteral's IPO is expected to be [●], after the finalization of basis of allotment. Investors can check Sai Parenteral's IPO allotment status on the registrars website, Bigshare Services Private Limited . Sai Parenteral's IPO refund dates are [●].
Sai Parenteral's IPO is expected to be listed on [●].
The upper price band for the Sai Parenteral's IPO is set at ₹ [●] per equity share. IPO price band is arrived at on the basis of IPO Valuation (P/E multiple) which is mentioned in the RHP.
For IPO analysis on Sai Parenteral's IPO, explore our Financial Review Page for insights on fundamentals, peer analysis, and key IPO data, assisting investors to make informed decisions to apply or not.
To apply for the Sai Parenteral's IPO, investors can use the ASBA (Application Supported by Blocked Amount) process via their bank's net banking or apply through UPI using a registered broker or trading app. The IPO is available in retail, HNI, and institutional investor categories. Investors must select the lot size, enter bid details within the price band, and submit their application before the IPO closing date of [●]. After submission, funds are blocked until the basis of allotment of Sai Parenteral's IPO is finalised.
The merchant banker for Sai Parenteral's IPO is Arihant Capital Markets Limited . Arihant Capital Markets Limited manages the IPO process, including underwriting, regulatory compliance, and investor coordination. Investors can refer to the Sai Parenteral's IPO RHP for further details.
The registrar for Sai Parenteral's IPO is Bigshare Services Private Limited . Investors can go to Bigshare Services Private Limited registrar website for IPO allotment status, refund processing, and other queries related to Sai Parenteral's IPO through their official website or helpline.
Sai Parenteral's IPO was subscribed [●] times. Stay updated on IPO details, subscription, and allotment news for informed investment decisions.
Get
Ready Image
IPO
Size:
[●]
Avg IPO Size (Sector Based)
:
₹ 1,326.67 Cr.
Sector: Pharmaceutical
IPO so far:
25
Merchant Banker:
Arihant Capital
IPO by BRLM so far:
4
City:
Telengana
IPO so far:
0
Revenue (annualised):
₹ 163.10 cr.
PE
Ratio:
[●]
Average Sector PE Ratio: 27.74x
Sai Parenteral's IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on Sai Parenteral's Financial Review Page
Merchant Banker(s) of Sai Parenteral's IPO: Arihant Capital Markets Limited
Sai Parenteral's IPO subscription was X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Sai Parenteral's IPO listed at a listing price of against the offer price of .
The current market price of Sai Parenteral's is .
Why Us?
